These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15724579)

  • 1. Transforming an industrial giant. Interview by Thomas A. Stewart and Louise O'Brien.
    von Pierer H
    Harv Bus Rev; 2005 Feb; 83(2):114-22, 150. PubMed ID: 15724579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Execution without excuses. Interview by Thomas A. Stewart and Louise O'Brien.
    Dell M; Rollins K
    Harv Bus Rev; 2005 Mar; 83(3):102-11, 150. PubMed ID: 15768680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CEO as organizational architect: an interview with Xerox's Paul Allaire. Interview by Robert Howard.
    Allaire P
    Harv Bus Rev; 1992; 70(5):106-21. PubMed ID: 10121313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leading change when business is good. Interview by Paul Hemp and Thomas A. Stewart.
    Palmisano S
    Harv Bus Rev; 2004 Dec; 82(12):60-70, 148. PubMed ID: 15605566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic sourcing: from periphery to the core.
    Gottfredson M; Puryear R; Phillips S
    Harv Bus Rev; 2005 Feb; 83(2):132-9, 150. PubMed ID: 15724581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to restore the fiduciary relationship. An interview with Eliot Spitzer. Interview by Louise O'Brien.
    Spitzer E
    Harv Bus Rev; 2004 May; 82(5):70-7, 150. PubMed ID: 15146737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp.
    Sharer K
    Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving change: an interview with Ford Motor Company's Jacques Nasser. Interview by Suzy Wetlaufer.
    Nasser J
    Harv Bus Rev; 1999; 77(2):76-88, 186. PubMed ID: 10387773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How CEOs manage growth agendas.
    Freeman KW; Nolen G; Tyson J; Lewis KD; Greifeld R; Gulati R
    Harv Bus Rev; 2004; 82(7-8):124-32, 189. PubMed ID: 15241959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
    Levin M
    Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To succeed in the long-term, focus on the middle-term.
    Moore GA
    Harv Bus Rev; 2007; 85(7-8):84-90, 192. PubMed ID: 17642127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right away and all at once: how we saved Continental.
    Brenneman G
    Harv Bus Rev; 1998; 76(5):162-4, 166, 168 passim. PubMed ID: 10185430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why doesn't this HR department get any respect?
    Galford R
    Harv Bus Rev; 1998; 76(2):24-6. PubMed ID: 10177864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case of the machinists' mutiny.
    Chew WB
    Harv Bus Rev; 1990; 68(6):14-7, 20, 24 passim. PubMed ID: 10107958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back where we belong.
    Critelli MJ
    Harv Bus Rev; 2005 May; 83(5):47-54, 152. PubMed ID: 15929403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for surviving a shakeout.
    Day GS
    Harv Bus Rev; 1997; 75(2):92-102. PubMed ID: 10165451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reshaping an industry: Lockheed Martin's survival story.
    Augustine NR
    Harv Bus Rev; 1997; 75(3):83-94. PubMed ID: 10167598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bob's meltdown.
    Carr NG
    Harv Bus Rev; 2002 Jan; 80(1):25-8; discussion 30-4, 124. PubMed ID: 12964466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giving great advice. Interview by Thomas A Stewart and Gardiner Morse.
    Wasserstein B
    Harv Bus Rev; 2008 Jan; 86(1):106-13, 138. PubMed ID: 18271322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance marketing: an interview with Nike's Phil Knight. Interview by Geraldine E. Willigan.
    Knight P
    Harv Bus Rev; 1992; 70(4):90-101. PubMed ID: 10119721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.